BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1382719)

  • 1. Genomic hypomethylation in human chronic lymphocytic leukemia.
    Wahlfors J; Hiltunen H; Heinonen K; Hämäläinen E; Alhonen L; Jänne J
    Blood; 1992 Oct; 80(8):2074-80. PubMed ID: 1382719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
    Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
    Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual role of HLXB9 in leukemia.
    Ferguson S; Gautrey HE; Strathdee G
    Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Certain changes in ornithine decarboxylase gene methylation accompany gene amplification.
    Wahlfors J
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):435-40. PubMed ID: 1719956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia.
    Lipsanen V; Leinonen P; Alhonen L; Jänne J
    Blood; 1988 Dec; 72(6):2042-4. PubMed ID: 2904292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse and human ornithine decarboxylase genes. Methylation polymorphism and amplification.
    Alhonen-Hongisto L; Leinonen P; Sinervirta R; Laine R; Winqvist R; Alitalo K; Jänne OA; Jänne J
    Biochem J; 1987 Feb; 242(1):205-10. PubMed ID: 3036086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
    Mills KI; Sproul AM; Burnett AK
    Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
    Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
    Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
    Tang Y; Deng C; Du Q; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
    Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
    Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
    Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
    Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation status within exon 3 of the c-myc gene as a prognostic marker in myeloma and leukaemia.
    Stephenson J; Akdag R; Ozbek N; Mufti GJ
    Leuk Res; 1993 Mar; 17(3):291-3. PubMed ID: 7680737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to dexamethasone induces hypomethylation of ornithine decarboxylase genes in a human myeloma cell line.
    Leinonen P; Alhonen-Hongisto L; Laine R; Jänne OA; Jänne J
    FEBS Lett; 1987 May; 215(1):68-72. PubMed ID: 3569540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
    Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
    Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Viswanathan K; Roboz G; Chadburn A; Mathew S
    Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
    Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
    Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
    Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary electrophoretic analysis of genomic DNA methylation levels.
    Stach D; Schmitz OJ; Stilgenbauer S; Benner A; Döhner H; Wiessler M; Lyko F
    Nucleic Acids Res; 2003 Jan; 31(2):E2. PubMed ID: 12527791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.